Image For Activity Cover
Bempedoic Acid: New Evidence Transforming the LDL-C Treatment Landscape
Description

This activity was planned with a goal to enable participants to learn best practices when prescribing bempedoic acid to the statin intolerant patient. This activity is part of the Bempedoic Acid: New Evidence Transforming the LDL-C Treatment Landscape grant supported by Esperion. 

 

Important Dates: 
Date of Release:
December 21, 2023
Term of Approval/Date of Expiration: December 22, 2024
 
Learner Objectives:  
Upon completion of this activity, you should be able to:

  1. Describe safety, efficacy, and long-term CV outcomes data of bempedoic acid based on clinical trial data. 

  1. Identify patients that would benefit from bempedoic acid and how to integrate this into practice.  

  1. Develop a treatment plan for the statin intolerant patient including the use of bempedoic acid. 


Acknowledgement 
Educational grant support provided by: Esperion.

Faculty:
Erin D. Michos, MD, MHS, FACC

Summary
Availability: On-Demand
Expires on Dec 22, 2024
Cost: FREE
Credit Offered:
No Credit Offered
Android App Download IOS App Download Powered By